| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | poly(A) binding | 3.07e-04 | 29 | 18 | 2 | GO:0008143 | |
| GeneOntologyMolecularFunction | poly-purine tract binding | 5.02e-04 | 37 | 18 | 2 | GO:0070717 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 2.30e-03 | 645 | 18 | 4 | GO:0140640 | |
| Domain | Nucleotide-bd_a/b_plait | 3.58e-06 | 258 | 18 | 5 | IPR012677 | |
| Domain | RRM | 5.99e-05 | 230 | 18 | 4 | PS50102 | |
| Domain | - | 7.53e-05 | 244 | 18 | 4 | 3.30.70.330 | |
| Domain | RRM_1 | 9.82e-04 | 208 | 18 | 3 | PF00076 | |
| Domain | zf-CCCH | 1.00e-03 | 49 | 18 | 2 | PF00642 | |
| Domain | RRM | 1.11e-03 | 217 | 18 | 3 | SM00360 | |
| Domain | RRM_dom | 1.26e-03 | 227 | 18 | 3 | IPR000504 | |
| Domain | Znf_CCCH | 1.40e-03 | 58 | 18 | 2 | IPR000571 | |
| Domain | ZF_C3H1 | 1.40e-03 | 58 | 18 | 2 | PS50103 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 2.52e-04 | 26 | 13 | 2 | MM14878 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 4.86e-04 | 36 | 13 | 2 | M633 | |
| Pathway | WP_MRNA_PROCESSING | 5.87e-04 | 451 | 13 | 4 | MM15946 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 6.31e-04 | 41 | 13 | 2 | MM14876 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 9.76e-04 | 51 | 13 | 2 | M665 | |
| Pathway | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | 1.09e-03 | 54 | 13 | 2 | MM15089 | |
| Pathway | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | 1.18e-03 | 56 | 13 | 2 | M839 | |
| Pathway | KEGG_RNA_DEGRADATION | 1.30e-03 | 59 | 13 | 2 | M963 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.21e-03 | 77 | 13 | 2 | MM14670 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.20e-06 | 724 | 18 | 6 | 36232890 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.74e-05 | 1155 | 18 | 6 | 20360068 | |
| Pubmed | 2.29e-05 | 14 | 18 | 2 | 24811271 | ||
| Pubmed | 2.67e-05 | 347 | 18 | 4 | 16033648 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 8.11e-05 | 462 | 18 | 4 | 31138677 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 8.85e-05 | 934 | 18 | 5 | 33916271 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.03e-04 | 179 | 18 | 3 | 36261009 | |
| Pubmed | 1.95e-04 | 40 | 18 | 2 | 16210410 | ||
| Pubmed | 1.98e-04 | 223 | 18 | 3 | 20020773 | ||
| Pubmed | O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma. | 2.90e-04 | 254 | 18 | 3 | 36604567 | |
| Pubmed | 2.92e-04 | 645 | 18 | 4 | 25281560 | ||
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 3.30e-04 | 52 | 18 | 2 | 24591637 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 3.50e-04 | 271 | 18 | 3 | 32433965 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 3.52e-04 | 678 | 18 | 4 | 30209976 | |
| Pubmed | 3.62e-04 | 274 | 18 | 3 | 34244482 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 3.90e-04 | 1284 | 18 | 5 | 17353931 | |
| Pubmed | 4.49e-04 | 295 | 18 | 3 | 26209609 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.45e-02 | 473 | 18 | 2 | chr17q21 | |
| GeneFamily | RNA binding motif containing | 1.71e-05 | 213 | 14 | 4 | 725 | |
| GeneFamily | Zinc fingers CCCH-type | 3.26e-04 | 35 | 14 | 2 | 73 | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 9.78e-07 | 194 | 18 | 4 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.34e-05 | 158 | 18 | 3 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | Ionocyte-iono-2|World / Class top | 4.37e-05 | 173 | 18 | 3 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | droplet-Marrow-BM|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 181 | 18 | 3 | 4169a1527b9c8f5783b8cc44e3a3924f8ed9a5e2 | |
| ToppCell | 5'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.33e-05 | 196 | 18 | 3 | a579211ef14f348d0c5a290553150222dfbf1515 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.52e-05 | 198 | 18 | 3 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.52e-05 | 198 | 18 | 3 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 6.72e-05 | 200 | 18 | 3 | b0ba486b55be18a4236bd2644f02352651f4b1fe | |
| Drug | Parthenolide [20554-84-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 3.87e-04 | 184 | 18 | 3 | 5530_UP | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 4.13e-04 | 188 | 18 | 3 | 5224_DN | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 4.46e-04 | 193 | 18 | 3 | 3229_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 2293_DN | |
| Drug | Labetalol hydrochloride [32780-64-6]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 3167_DN | |
| Drug | Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; HL60; HG-U133A | 4.73e-04 | 197 | 18 | 3 | 1713_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; HL60; HG-U133A | 4.73e-04 | 197 | 18 | 3 | 1591_UP | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 5534_UP | |
| Drug | Sulfabenzamide [127-71-9]; Up 200; 14.4uM; HL60; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 2159_UP | |
| Drug | AR E | 7.42e-04 | 230 | 18 | 3 | CID004369394 | |
| Disease | alcohol consumption measurement | 7.10e-04 | 1242 | 18 | 5 | EFO_0007878 | |
| Disease | aspartate aminotransferase measurement | 1.90e-03 | 904 | 18 | 4 | EFO_0004736 | |
| Disease | corneal resistance factor | 2.44e-03 | 451 | 18 | 3 | EFO_0010067 | |
| Disease | response to vaccine | 2.48e-03 | 122 | 18 | 2 | EFO_0004645 | |
| Disease | Global developmental delay | 2.94e-03 | 133 | 18 | 2 | C0557874 | |
| Disease | dyslexia | 4.33e-03 | 162 | 18 | 2 | EFO_0005424 | |
| Disease | coronary artery disease | 5.18e-03 | 1194 | 18 | 4 | EFO_0001645 | |
| Disease | dental caries | 5.72e-03 | 187 | 18 | 2 | EFO_0003819 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KAKQNNNNRKTSNGD | 411 | P13569 | |
| NKQKSKYLRGNRNSQ | 511 | Q96BT7 | |
| NGRKQYQDSPNQKKR | 321 | Q8IU60 | |
| QGNNNQNKPGFLRKN | 581 | Q9P2N5 | |
| GQKKRQNQSKYTQNG | 226 | Q6XE24 | |
| KEVYRQQQQQQKGGR | 311 | O14979 | |
| PQKYKQVTNGQGENK | 651 | O60271 | |
| GGNRVNNAKNKRTNN | 2631 | Q2LD37 | |
| YQWQKGQMQKQNGGK | 541 | Q9H0J9 | |
| GQNGQKKYQINLKSH | 206 | Q15329 | |
| KTEGYRKQQQRQQQQ | 286 | Q8TAL5 | |
| GGNKSNRSQNKGQKR | 761 | Q9NR30 | |
| DKGDKKNQQQQQGNN | 366 | P49336 | |
| QQYAKSKKQGNSSNS | 86 | Q01668 | |
| KNGKNETGNNNNKDG | 186 | Q9H9A5 | |
| KEGNQDNKNVNVNKY | 396 | Q8TDR2 | |
| QNQGKKAEGAQNQGK | 306 | Q9P2E9 | |
| QNQGKKGEGAQNQGK | 316 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 326 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 336 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 346 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 356 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 366 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 376 | Q9P2E9 | |
| QNQGKKVEGAQNQGK | 386 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 396 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 406 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 416 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 426 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 436 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 446 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 456 | Q9P2E9 | |
| QNQGKKVEGAQNQGK | 466 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 476 | Q9P2E9 | |
| QNQGKKAEGAQNQGK | 486 | Q9P2E9 | |
| AQNGLQNAQQQGKKK | 41 | Q8N841 | |
| KKKNTVFQQGTQQTY | 846 | Q86YA3 |